|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
AxoGen, Inc. (LECT) Announces Release Dates for 2012 Third Quarter Results and Conference Call
10/26/2012 7:42:27 AM
ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions, today announced that it will release its financial results for the period ended September 30, 2012, on November 7, 2012 after the close of U.S. financial markets. A conference call hosted by Karen Zaderej, Chief Executive Officer, and Greg Freitag, Chief Financial Officer, will follow at 11:00 a.m. ET, on November 8, 2012.
|
|
|
|
|
|
|
|
|
|
|